Updated 06.24.2026
Written by Rachel De La Merced and reviewed by Board Certified Psychiatric Nurse Practitioner Kate Filippelli, PMHNP who specializes in evidence-based psychiatry practices with personalized treatment plans for all mental health challenges, including psychiatric medication management, research-based supplements and behavioral interventions for major depressive disorder, bipolar disorder, anxiety, panic, OCD, ADHD and eating disorders.
Attention-deficit/hyperactivity disorder (ADHD) is often thought of as a condition defined by focus, organization, and impulse control. Depression, by contrast, is usually associated with low mood, loss of interest, and emotional withdrawal. In real life, however, these conditions frequently overlap. Research consistently shows that ADHD and depression co-occur at much higher rates than would be expected by chance, and when they do, the impact on daily functioning is often greater than either condition alone [1-3]. At Remedy, we’ve often observed that this overlap can also make symptoms more difficult to recognize, as each condition may mask or intensify the other.
Understanding how and why ADHD and depression intersect can help individuals and families recognize symptoms earlier, seek appropriate evaluation, and make informed decisions about treatment. This is especially important in telepsychiatry settings, where access to psychiatric providers and medication management may happen entirely online.
How common is depression in people with ADHD?
Large, high-quality studies show that individuals with ADHD are approximately 5.5 times more likely to develop depression compared with those without ADHD [1]. In children and adolescents, pooled estimates from recent meta-analyses suggest that about 11% meet criteria for depression at some point, with higher rates observed among females [2]. In adults, comorbidity rates are even higher, particularly in those whose ADHD was never formally diagnosed or treated earlier in life [11]. As a psychiatric nurse practitioner at Remedy, I’ve encountered adults presenting with depression first, only to later realize that untreated ADHD has been an underlying factor for years, especially in individuals who were never formally diagnosed in childhood
This overlap matters because comorbid ADHD and depression is associated with more severe symptoms, greater functional impairment, and poorer long-term outcomes. Individuals with both conditions are more likely to struggle academically or professionally, experience relationship difficulties, and report lower overall quality of life than those with either ADHD or depression alone [3].
Why does ADHD increase the risk of depression?
The pathways linking ADHD and depression are complex and multifactorial. Many people wonder, “can ADHD cause depression?” Longitudinal research suggests that ADHD does not directly “cause” depression in a simple way. While attention-deficit disorders do not automatically lead to depression, ADHD-related challenges can increase vulnerability to mood symptoms over time. Instead, ADHD-related challenges can set the stage for later mood symptoms through social, academic, and emotional mechanisms.
One key factor is peer and academic functioning. Children with ADHD often experience difficulties with friendships, classroom behavior, and academic performance. These challenges can accumulate over time, leading to repeated experiences of criticism, rejection, or perceived failure. Studies indicate that peer relationship problems and academic underachievement together explain roughly 15-20% of the association between childhood ADHD and later depression [1,4]. Importantly, it is inattention symptoms, rather than hyperactivity, that appear most strongly linked to this pathway, likely because inattention interferes with communication, follow-through, and social reciprocity [5].
Another important contributor is emotion regulation. Youth with ADHD are more likely to rely on maladaptive cognitive emotion-regulation strategies, such as rumination, catastrophizing, and self-blame. These strategies are strongly correlated with depressive symptom severity and can make it harder to recover from everyday stressors [6]. Over time, difficulty shifting attention away from negative thoughts may deepen and prolong low mood. In our clinical experience at Remedy, we’ve observed how emotional regulation challenges are a major piece of the puzzle. Many individuals with ADHD experience intense emotional responses and have difficulty shifting out of negative thought patterns, which can increase vulnerability to depression
There is also growing evidence for shared neurocognitive vulnerabilities. Systematic reviews have identified overlapping deficits in executive functions – such as working memory, selective attention, and verbal fluency – in individuals with ADHD and those with depressive disorders [7]. These shared cognitive features may represent pre-existing risk markers that increase susceptibility to both conditions, particularly when combined with environmental stress.
Challenges in clinical assessment
Accurately identifying ADHD and depression when they occur together can be difficult. Many symptoms overlap, including poor concentration, low motivation, fatigue, and sleep disruption. Standard symptom questionnaires, while useful, often have limited ability to distinguish between ADHD, depression, and comorbid presentations on their own.
Clinical guidelines from the Society for Developmental and Behavioral Pediatrics emphasize the importance of first determining which condition is causing greater functional impairment, while also screening carefully for red flags such as suicidal ideation, psychosis, or severe functional decline that may require urgent intervention [8,9]. This approach helps psychiatric providers prioritize treatment in a way that is both safe and clinically meaningful.
Recent research highlights the added value of assessing executive functioning as part of the diagnostic process. Studies show that incorporating executive-function measures alongside symptom ratings can dramatically improve diagnostic accuracy for comorbid ADHD and depression, increasing correct classification rates from near zero to over 40% in some samples [10]. A comprehensive evaluation typically includes a detailed developmental history, clinical interviews, standardized rating scales, and careful consideration of cognitive patterns rather than relying on checklists alone.
Telepsychiatry can support this level of assessment by allowing psychiatric providers to conduct structured interviews and follow-up evaluations remotely, reducing barriers to care while maintaining clinical rigor.
Evidence-based treatment approaches
Treatment planning for individuals with ADHD and depression depends on symptom severity, functional impact, age, and safety considerations. Current guidelines consistently recommend individualized, staged care rather than a single, uniform approach [8].
When depression is the more impairing condition, evidence-based psychotherapies – such as cognitive-behavioral therapy or interpersonal therapy – are often recommended as first-line treatments, with antidepressant medication added if psychosocial interventions alone are insufficient [8]. While psychotherapy plays an important role in many treatment plans, some telepsychiatry practices, including Remedy Psychiatry, focus specifically on medication management and may coordinate care or provide referrals when therapy is indicated.
When ADHD symptoms predominate, behavioral and pharmacologic treatments for ADHD often lead to improvements not only in attention and organization but also in internalizing symptoms such as anxiety and low mood. Research suggests that children with ADHD and comorbid internalizing symptoms may respond particularly well to structured ADHD interventions [8].
In more severe or persistent cases, especially in adults, combined treatment approaches are frequently necessary. Reviews of adult ADHD note that comorbid depression often requires coordinated management, which may include ADHD medications alongside antidepressants, with careful monitoring for symptom changes and side effects over time [11]. Medication decisions are individualized and should always be guided by a qualified psychiatric provider.
When to seek psychiatric care
It may be helpful to seek a psychiatric evaluation if ADHD symptoms are accompanied by persistent low mood, loss of interest, irritability, or noticeable declines in school, work, or relationship functioning. Changes that last for weeks or months, rather than days, are especially important to address.
Urgent evaluation is warranted if there are concerns about suicidal thoughts, self-harm, psychosis, or severe behavioral changes. Clinical guidelines stress the importance of identifying these red flags early to ensure safety and appropriate care [8,9].
Telepsychiatry and next steps
For many individuals managing ADHD and depression, consistent follow-up and medication monitoring are key parts of care. Telepsychiatry offers a flexible way to engage with psychiatric providers while maintaining continuity and oversight. At Remedy, we emphasize that seeking support is an important first step. Early evaluation and intervention can significantly improve both short- and long-term outcomes
Remedy Psychiatry provides telepsychiatry-based medication management. When psychotherapy or additional support are recommended, coordination with outside providers may be part of the care plan. If you are exploring medication management through telehealth, you can book an appointment through Remedy’s telepsychiatry services to learn more about available options.
Disclaimer:
This article is for educational purposes only and does not constitute medical advice. Treatment decisions should always be made with a qualified psychiatric provider based on individual circumstances.
References
-
https://pmc.ncbi.nlm.nih.gov/articles/PMC13187293/
-
https://pmc.ncbi.nlm.nih.gov/articles/PMC12318167/
-
https://acamh.onlinelibrary.wiley.com/doi/10.1111/jcpp.13678
-
https://pmc.ncbi.nlm.nih.gov/articles/PMC7595988/
-
https://psycnet.apa.org/doiLanding?doi=10.1037%2Fa0033895
-
https://pmc.ncbi.nlm.nih.gov/articles/PMC9279209/
-
https://www.sciencedirect.com/science/article/abs/pii/S0149763420306825?via%3Dihub
-
https://journals.lww.com/jrnldbp/fulltext/2020/03001/society_for_developmental_and_behavioral.3.aspx
-
https://journals.lww.com/jrnldbp/fulltext/2020/03001/the_society_for_developmental_and_behavioral.4.aspx
-
https://www.sciencedirect.com/science/article/abs/pii/S0022395623003801?via%3Dihub
-
https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2025.1597559/full




